Advertisement
Screener

QIAGEN N.V. (QGEN) Deferred Income Tax Expense (Benefit)

1.6 / 5 stars · 19/59 Roast Me

QIAGEN N.V. Deferred Income Tax Expense (Benefit)

QIAGEN N.V. (QGEN) reported Deferred Income Tax Expense (Benefit) of -$20.07 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-20.

Financial Statements › Cash Flow › Operating Activities

us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-03-20

Period endDeferred Income Tax Expense (Benefit) 12 monthDeferred Income Tax Expense (Benefit) 12 month as first filed
2025-12-31-$20.07M
20-F · filed 2026-03-20
2024-12-31-$23.04M
20-F · filed 2026-03-20
2023-12-31$10.73M
20-F · filed 2026-03-20
2022-12-31-$9.60M
20-F · filed 2025-03-31
2021-12-31-$5.29M
20-F · filed 2024-03-11
2020-12-31-$6.71M
20-F · filed 2023-03-13
2019-12-31-$55.36M
20-F · filed 2022-03-14
2018-12-31-$23.27M
20-F · filed 2021-03-05
2017-12-31$60.18M
20-F · filed 2020-03-02
2016-12-31-$63.98M
20-F · filed 2019-03-06
-$65.97M
20-F · filed 2017-03-06
2015-12-31-$32.28M
20-F · filed 2018-03-06
-$37.19M
20-F · filed 2016-02-29
2014-12-31-$40.15M
20-F · filed 2017-03-06
-$41.29M
20-F · filed 2015-03-02
2013-12-31-$68.09M
20-F · filed 2016-02-29
2012-12-31-$22.77M
20-F · filed 2015-03-02
2011-12-31-$31.86M
20-F · filed 2014-03-03
2010-12-31-$19.94M
20-F · filed 2013-03-04
2009-12-31-$10.61M
20-F · filed 2012-03-27
2008-12-31-$2.56M
20-F · filed 2011-03-21